the publisher's Medical Devices sector report, “Cardiac Rhythm Management Devices - Medical Devices Pipeline Product Landscape, 2021' provides comprehensive information about the Cardiac Rhythm Management Devices pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in progress.
Cardiac Rhythm Management (CRM) devices are those devices which are used to restore the natural synchronized pumping rhythm of the heart. These include Pacemakers, Cardiac Resynchronisation Therapy (CRT), Implantable Loop Recorders and Implantable Cardioverter Defibrillators (ICD).
Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.
– Extensive coverage of the Cardiac Rhythm Management Devices under development
– The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
– The report reviews the major players involved in the development of Cardiac Rhythm Management Devices and list all their pipeline projects
– The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
– The report provides key clinical trial data of ongoing trials specific to pipeline products
– Recent developments in the segment / industry
The report enables you to -
– Formulate significant competitor information, analysis, and insights to improve R&D strategies
– Identify emerging players with potentially strong product portfolio and create effective counter strategies to gain competitive advantage
– Identify and understand important and diverse types of Cardiac Rhythm Management Devices under development
– Develop market-entry and market expansion strategies
– Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
– In-depth analysis of the product’s current stage of development, territory and estimated launch date
Cardiac Rhythm Management (CRM) devices are those devices which are used to restore the natural synchronized pumping rhythm of the heart. These include Pacemakers, Cardiac Resynchronisation Therapy (CRT), Implantable Loop Recorders and Implantable Cardioverter Defibrillators (ICD).
Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.
Scope
– Extensive coverage of the Cardiac Rhythm Management Devices under development
– The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
– The report reviews the major players involved in the development of Cardiac Rhythm Management Devices and list all their pipeline projects
– The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
– The report provides key clinical trial data of ongoing trials specific to pipeline products
– Recent developments in the segment / industry
Reasons to Buy
The report enables you to -
– Formulate significant competitor information, analysis, and insights to improve R&D strategies
– Identify emerging players with potentially strong product portfolio and create effective counter strategies to gain competitive advantage
– Identify and understand important and diverse types of Cardiac Rhythm Management Devices under development
– Develop market-entry and market expansion strategies
– Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
– In-depth analysis of the product’s current stage of development, territory and estimated launch date
Table of Contents
1 Table of Contents
2 Introduction
3 Products under Development
4 Cardiac Rhythm Management Devices - Pipeline Products under Development by Companies
7 Appendix
List of Tables
List of Figures
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- A3 Remote Monitoring Technologies Pvt Ltd
- Abbott Medical
- Advanced BioInformatics GmbH
- AIS Inc.
- Angel Medical Systems Inc
- Arizona State University
- Arrhythmia Dynamics LLC
- AtaCor Medical Inc
- Bionet Sonar Inc
- Biotronik AG
- Biotronik SE & Co KG
- Boston Scientific Corp
- Boston TransTec LLC
- Cairdac
- CardiaLen, Inc.
- Cardioalarm, Inc
- Children’s National Health System
- Corhythm Inc
- Coridea, LLC
- CVRx Inc
- DHS Medical
- Drexel University
- Duke University
- EBR Systems Inc
- Endurance Rhythm Inc.
- Hadassah Medical Center
- Impulse Dynamics NV
- InnerPulse Inc (Inactive)
- Integer Holdings Corp
- IRadimed Corp
- Johns Hopkins University
- Kenergy Inc.
- Krisara Engineering, LLC
- Massachusetts General Hospital
- Max Planck Institute for Dynamics and Self-Organization
- Mayo Clinic
- Medicool Technologies Inc
- Medtronic Inc
- Medtronic Plc
- MicroPort CRM SA
- MicroPort Scientific Corp
- NanoLinea
- NewPace Ltd
- Northwestern University
- NuVascular Technologies Inc
- Odem Medical Ltd
- Ohio State University
- Osypka Medical GmbH
- Perpetuum Ltd
- Queen Mary University of London
- Rice University
- Shaanxi Qinming Medical Instruments Co Ltd
- Smartwave Medical Ltd (Inactive)
- Spectranetics Corp
- St. Jude Medical LLC
- SUNY Downstate Medical Center
- Suzhou Wushuang Medical Equipment Co Ltd
- Teleflex Inc
- Thayer School of Engineering at Dartmouth
- U.S. Stem Cell Inc
- University of Bern
- University of California Los Angeles
- University of Chicago
- University of Glasgow
- University of Michigan
- University of Southern California
- University of Utah
